NEWS
You can follow the latest news of MicroViable in this section
Microviable received the MRR High-Impact Paper Award
Microviable has received the 2025 Microbiome Research Reports High-Impact Paper Award, a recognition to an outstanding scientific review manuscript published in 2025 in the journal Microbiome Research Reports. Our CTO, David Ríos Covián, PhD, lead [...]
Microviable present at the Microbiome Times Partnering Forum
During March 18-19th, Microviable will be attending the Microbiome Times Partnering Forum taking place in Copenhagen, joining other cutting-edge biotech companies, VCs, and pharma companies during the two days of the event. Microviable will have [...]
Two Projects funded under CanSERV European call
Microviable obtained two projects funded under CanSERV European call focused on "Reaching and Understanding of Cancer". We are proud to announce that our research proposal “Exploring the relationships between anti-PD1 responders and gut microbiota: intervention [...]
Projects awarded SEKUENS
At Microviable we are proud and thankful to SEKUENS, Agencia de Ciencia, Competitividad Empresarial e Innovación del Principado de Asturias, for the four projects approved in 2025 with competitive funding! We will keep pushing for [...]
Pilar Manrique will present at 10th Microbiome Movement Summit
Pilar Manrique, PhD, senior scientist at Microviable Therapeutics will be present at the 10th Microbiome Microbiome Movement Summit taking place in London, in January 28-29th 2026! Pilar Manrique will be presenting on Thursday 29th at [...]
Claudio Hidalgo presenting at LSX Inv€$stival Showcase
Microviable Therapeutics will be attending LSX Inv€$tival Showcase Claudio Hidalgo, PhD, cofounder and CEO and Noelia Martínez, PhD, cofounder and R&D Director at Microviable Therapeutics, will be attending LSX Inv€$tival Showcase in London on November [...]